有机硅橡胶固定化细胞进行的生物转化

有机硅橡胶固定化细胞进行的生物转化潘冰峰,戴学倩,冯青,李祖义（中国科学院上海有机化学研究所,２０００３２）关键词硅橡胶;白地霉;固定化细胞;生物转化近年来,有机化学领域的一个重要进展是用酶或微生物进行生物转化反应。其中研究和应用较多的是碳基还原,特...     

微生物发酵生产5-氨基乙酰丙酸研究进展

5-氨基乙酰丙酸是生物体内吡咯生物合成途径的关键中间产物,具有广泛的应用前景。文中从三方面归纳了国内外关于5-氨基乙酰丙酸的最新研究进展:生产5-氨基乙酰丙酸的微生物筛选分离与诱变;基于C4途径的微生物全细胞生物转化合成5-氨基乙酰丙酸;基于微生物代谢工程改造构建高产5-氨基乙酰丙酸的工程菌株。最后,预测了未来5-氨基乙酰丙酸的研究方向和焦点。     

微生物药物生物合成知识库研究进展

<正>微生物次级代谢途径是微生物药物生物合成的内在基础,微生物药物生物合成涉及一系列的生物转化反应、途径和网络。目前,大多数潜在有用的次级代谢生物转化反应还分散在海量的文献中,因此,生物转化反应的数据集成以及基于生物转化反应建立的生物合成转化模式的数据库匮乏已成为生     

微生物转化在医药工业中的应用

微生物转化与医药工业间的关系密切,微生物转化技术在医药工业中的应用具有明显优势。近年来,随着微生物转化技术的不断发展,将微生物转化技术应用于医药工业已逐渐成为医药工业的发展趋势。本文主要介绍微生物转化技术的概念、特点及方法,并对微生物转化在医药工业中的主要应用方面进行深入阐述,使人们更好地认识到微生物转化的重要性。     

固定化细胞在有机相中的催化反应

１引言近年来固定化细胞（主要是微生物细胞）在有机相中的催化反应已有不少报导,与固定化酶在有机介质催化反应相比,具有一定的优点［１,２］：（１）减少了酶的分离、纯化过程。（２）微生物细胞含有一系列量少且在纯或半纯状态下不稳定的酶,许多生物转化过程可在酶...     

微生物转化技术在中药开发中的应用进展

中药现代化是目前中药研究最迫切的需要,微生物转化技术可以利用微生物的特性解决中药现代化研究中难以解决的诸多问题,我们总结了微生物转化中药的特点,转化酶系统及反应类型,分析了微生物生物转化对中药的影响,认为微生物转化技术酶系统广泛,选择性强,反应条件温和可控,反应类型广泛,适用于所有类型的中药有效成分的生物转化,经过转化后,可以提高中药药效,降低毒性,去除杂质,帮助有效成分的体内代谢及产生新的药物成分。中药微生物转化技术必定成为中药学与微生物学完美契合的典范,推进中药现代化的进程。     

南沙链霉菌来源细胞色素P450酶CYP154C34的表征及生物转化

【目的】P450酶作为一种多功能生物催化剂,可在温和条件下高区域和立体选择性地催化复杂化合物中未活化的C-H键,因此P450酶在化工原料合成、环境污染物降解及药物合成等领域都具有重要作用。本文对南沙链霉菌基因组中的一个新颖的P450酶CYP154C34进行研究,通过构建异源表达和全细胞生物转化重组菌探究其功能。【方法】构建2种全细胞生物转化BL21(DE3)重组菌(含p ET28a-CYP154C34-RhFRED和pET28a-CYP154C34+pACYCDuet-Pdx/PdR)和1种异源表达BL21(DE3)重组菌(含pET28a-CYP154C34)。通过全细胞生物转化的方式筛选底物,分析催化功能及产物结构。比较2种全细胞生物转化重组菌和体外酶反应对底物的转化率。分析CYP154C34和不同底物及底物类似物的亲和力。【结果】通过底物筛选和产物鉴定发现CYP154C34可催化包括孕酮、睾酮、雄烯二酮在内的9种甾体化合物16α位羟基化。通过2种不同还原伴侣的全细胞体系及体外酶反应对底物转化率的比较,发现含有pET28a-CYP154C34-RhFRED的BL21(DE3)重组菌的...     

甾体微生物转化在制药工业中的应用

对几种重要的甾体微生物转化反应如甾体边链降解、甾体羟基化反应的机理及其发展与应用作了概述;同时也介绍了固定化微生物细胞、非水溶液中酶催化反应及混合发酵等微生物转化技术在制药工业中的应用。     

天然活性先导化合物生物转化研究进展

天然活性先导化合物生物转化是利用生物催化剂(如：酶、微生物、动植物细胞)将加入到生物反应系统中的天然活性先导化合物进行特异性的分子结构修饰以获得高效、低毒新化合物的方法。该方法可以有效地提高已知的天然活性先导化合物的活性、降低毒副作用、改善水溶性和生物利用度,也可以用来生产具有重要应用价值的微量天然活性先导化合物,同时可用于药物代谢机制的研究。国内外学者已经针对甾体、醌类、黄酮类、萜类等化合物开展了天然活性先导化合物生物转化研究,筛选出一批有重要应用价值的生物转化反应类型,但针对天然活性先导化合物生物转化的机制、生物转化过程工程以及生物转化产物活性等方面的研究较少。将现代生命科学技术(如：生物催化剂的定向改造、高通量筛选、组合生物转化、非水相生物转化)引入天然活性先导化合物生物转化研究中,必将推进天然活性先导化合物的快速发展。     

有机溶剂对细胞的毒害及细胞的耐受性机制*

在非水相生物转化和涉及有机溶剂的环境微生物技术中,有机溶剂对微生物细胞的毒性使相关的研究和应用受到制约,这些有机分子进入到细胞膜中,破坏膜的完整性、增加膜的通透性,使细胞死亡;但在一些情况下,某些微生物可以通过自身的抗性机制在有机溶剂中存活,而微生物对有机溶剂的耐受性主要取决于物理障碍、细胞膜水平、主动泵出系统3个层次上相应的生理生化作用。     

Bioprocess engineering: now and beyond 2000

Abstract: Bioprocess engineering may be defined as the translation of life-science discoveries into practical products, processes, or systems capable of serving the needs of society. It is a critical link from discovery to commercialization. Current bioprocess engineering is primarily focused on biopharmaceutical products of high dollar value per gram such as erythropoietin or growth hormones. However, other products of current interest include ethanol, amino acids, organic acids, antibiotics, and specialty chemicals. Current challenges for increased use of bioprocesses for producing bulk and semi-bulk chemicals include both technical and infrastructural barriers. Technical barriers are easy to identify and at times can be overcome by engineering improvements or changes brought about radical developments in science (e.g. recombinant DNA). Infrastructural barriers, such as raw-material substitutions or educational limitations are more difficult to define and change. Recently the National Academy of Sciences examined barriers to bioprocess engineering and issued a report entitled: "Putting Biotechnology to Work: Bioprocess Engineering". A key recommendation was the establishment of a coordinated long-range plan of research, development, training and education in bioprocess engineering involving participation by industry, academe and the federal government. The report was the first national analysis devoted entirely to bioprocess engineering and covered new topics such as space bioprocess engineering. Other topics covered by the author include the current state of the US chemical industry and future directions in three promising areas of bioprocess engineering environmental bioprocess engineering, marine bioprocess engineering and microsystem bioprocess engineering.     

以生物合成为基础的代谢工程和组合生物合成

代谢工程和组合生物合成在筛选和发展新型药物方面日益成为生物、化学和医药界关注的重点。基于聚酮和聚肽类天然产物的独特化学结构和良好生物活性,研究它们的生物合成机制,将为合理化遗传修饰生物合成途径获得结构类似物提供遗传和生物化学的基础,实现利用现代生物学和化学的技术手段在微生物体内进行药物开发的目的。     

Rational design of thiolase substrate specificity for metabolic engineering applications

Metabolic engineering efforts require enzymes that are both highly active and specific toward the synthesis of a desired output product to be commercially feasible. The 3‐hydroxyacid (3HA) pathway, also known as the reverse β‐oxidation or coenzyme‐A‐dependent chain‐elongation pathway, can allow for the synthesis of dozens of useful compounds of various chain lengths and functionalities. However, this pathway suffers from byproduct formation, which lowers the yields of the desired longer chain products, as well as increases downstream separation costs. The thiolase enzyme catalyzes the first reaction in this pathway, and its substrate specificity at each of its two catalytic steps sets the chain length and composition of the chemical scaffold upon which the other downstream enzymes act. However, there have been few attempts reported in the literature to rationally engineer thiolase substrate specificity. In this study, we present a model‐guided, rational design study of ordered substrate binding applied to two biosynthetic thiolases, with the goal of increasing the ratio of C6/C4 products formed by the 3HA pathway, 3‐hydroxy‐hexanoic acid and 3‐hydroxybutyric acid. We identify thiolase mutants that result in nearly 10‐fold increases in C6/C4 selectivity. Our findings can extend to other pathways that employ the thiolase for chain elongation, as well as expand our knowledge of sequence–structure–function relationship for this important class of enzymes.     

植物来源药用天然产物的合成生物学研究进展

大多数药用天然产物在植物中含量低微,提取分离困难;而且这些化合物一般结构复杂,化学合成难度大,还容易造成环境污染.基于合成生物学技术获得药用天然产物具有绿色环保和可持续发展等优点.文中以药用萜类化合物人参皂苷、紫杉醇、青蒿素、丹参酮,生物碱类化合物长春新碱、吗啡以及黄酮类化合物灯盏花素为例,总结了植物来源药用萜类、生物...     

Integrated ecological engineering of corn utilization in Zhaodong County

Basing on fundamental principles of ecological engineering, the conversion, reuse and recycling of products, by-products, and waste in the processing of corn, straw, cob and root from a certain county have been designed and put into practice. The design is an integration of many techniques including chemical, biological and physical ones suited to local conditions. Some results with a great potential have been obtained.     

Computational evaluation of Synechococcus sp. PCC 7002 metabolism for chemical production

Cyanobacteria are ideal metabolic engineering platforms for carbon-neutral biotechnology because they directly convert CO₂ to a range of valuable products. In this study, we present a computational assessment of biochemical production in Synechococcus sp. PCC 7002 (Synechococcus 7002), a fast growing cyanobacterium whose genome has been sequenced, and for which genetic modification methods have been developed. We evaluated the maximum theoretical yields (mol product per mol CO₂ or mol photon) of producing various chemicals under photoautotrophic and dark conditions using a genome-scale metabolic model of Synechococcus 7002. We found that the yields were lower under dark conditions, compared to photoautotrophic conditions, due to the limited amount of energy and reductant generated from glycogen. We also examined the effects of photon and CO₂ limitations on chemical production under photoautotrophic conditions. In addition, using various computational methods such as minimization of metabolic adjustment (MOMA), relative metabolic change (RELATCH), and OptORF, we identified gene-knockout mutants that are predicted to improve chemical production under photoautotrophic and/or dark anoxic conditions. These computational results are useful for metabolic engineering of cyanobacteria to synthesize value-added products.     

平台化学品短链支链脂肪酸和短链支链醇的微生物代谢工程

短链支链脂肪酸和短链支链醇均为重要的平台化学品,是合成多种高附加值产品的前体物质,市场需求巨大。目前两者的生产主要是利用基于石化原料的化学合成法。化学合成法存在着严重依赖化石燃料、反应效率低以及极易造成环境污染等缺点。微生物代谢工程的快速发展为这些平台化学品的生产提供了一条极具潜力的生物合成路线。利用微生物代谢工程技术构建生产这些平台化学品的微生物细胞工厂具有绿色清洁、可持续发展和经济效益好等独特优势。本文系统综述了近年来微生物代谢工程技术在短链支链脂肪酸和短链支链醇合成方面的研究进展,包括所涉及的宿主菌株、关键酶、代谢途径及其改造等,并探讨了未来的发展前景。     

代谢工程改造解脂耶氏酵母合成植物萜类化合物的研究进展

萜类化合物是一类广泛存在于植物中的天然产物,其在食品、药品和化工等多个领域中均有广泛的用途,市场潜力巨大。因此,开发生产萜类化合物等植物天然产物可再生的微生物资源来补充甚至代替原有稀少和珍贵的植物资源,具有重要的理论意义和潜在的应用价值。解脂耶氏酵母是目前使用最广泛的非常规酵母底盘细胞之一。近年来,利用代谢工程及合成生物学技术在解脂耶氏酵母底盘细胞中重构与优化萜类化合物的合成途径以实现目标代谢产物的高效合成,已经成为一项研究热点。本文系统总结了有关利用解脂耶氏酵母作为底盘细胞异源生产植物萜类化合物的具体实例和最新进展,包括所涉及的宿主菌株、关键酶、代谢途径及改造策略等,并在最后对该领域的未来发展方向进行了展望。     

丝素蛋白材料在皮肤创伤愈合中的研究进展

摘要：丝素蛋白是一种天然的高分子纤维蛋白,其结构的特殊性决定了较好的机械性能,再因其优良的生物相容性、降解产物无毒等特点,被广泛用于各种材料的研究。通过各种化学修饰和负载生长因子等,使丝素蛋白在体内外具有促进成纤维细胞增殖分化的作用,拥有诱导创面愈合的功能,同时其可部分降解,具有缓释性能好,柔韧性强,透气以及透水等较好的理化性质不但在皮肤组织工程学中的广泛的应用,并且在敷料领域的研究也显示了其治疗烧烫伤、创伤达到抑制疤痕、促进伤口快速愈合的治疗效果。总之,通过改良丝素蛋白材料的加工方法,通过化学修饰、其他物质复合等手段得到适合于皮肤修复的具有优良性能的各种材料,是具有很大潜力的极具临床价值的皮肤修复材料。本文旨在综述国内及国外学者的各种关于丝素蛋白生物材料治疗皮肤损伤的研究最新进展。     

Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health

Plant natural products derived from phenylalanine and the phenylpropanoid pathway are impressive in their chemical diversity and are the result of plant evolution, which has selected for the acquisition of large repertoires of pigments, structural and defensive compounds, all derived from a phenylpropanoid backbone via the plant-specific phenylpropanoid pathway. These compounds are important in plant growth, development and responses to environmental stresses and thus can have large impacts on agricultural productivity. While plant-based medicines containing phenylpropanoid-derived active components have long been used by humans, the benefits of specific flavonoids and other phenylpropanoid-derived compounds to human health and their potential for long-term health benefits have been only recognized more recently. In this part of the review, we discuss the diversity and biosynthetic origins of phenylpropanoids and particularly of the flavonoid and stilbenoid natural products. We then review data pertaining to the modes of action and biological properties of these compounds, referring on their effects on human health and physiology and their roles as plant defense and antimicrobial compounds. This review continues in Part II discussing the use of biotechnological tools targeting the rational reconstruction of multienzyme pathways in order to modify the production of such compounds in plants and model microbial systems for the benefit of agriculture and forestry.